2025. CLINICAL IMMUNOBIOCHEMICAL MARKERS IN OPTIMIZING THE DIAGNOSTICS OF BRONCHIAL ASTHMA IN COMORBIDITY WITH TYPE 2 DIABETES MELLITUS. Modern American Journal of Medical and Health Sciences. 1, 8 (Nov. 2025), 51–63.